Article Text

Download PDFPDF
Learning from errors
Continuous renal replacement treatment and the ‘bleeding patient’
  1. Hugh Davies1,2,
  2. Gavin Leslie1,2,
  3. David Morgan1
  1. 1Intensive Care Unit, Royal Perth Hospital, Perth, Western Australia
  2. 2School of Nursing & Midwifery, Curtin University of Technology, Perth, Western Australia
  1. Correspondence to Hugh Davies, hugh.davies{at}health.wa.gov.au

Summary

A woman suspected of intra-abdominal bleeding with end-stage renal failure requiring maintenance haemodialysis was treated with continuous veno-venous haemodiafiltration in the intensive care unit. The use of citrate restricted to the extracorporeal circuit maintained continuity of treatment and avoided the adverse affects of systemic anticoagulation. Regional citrate anticoagulation was achieved using the ‘modified’ Alabama Protocol. A description of the protocol is included along with troubleshooting instructions. Violations of the protocol challenged the adequacy of workforce training and patient monitoring, which saw systemic ionised calcium level reach 0.62 mmol/litre and base deficit drop −14.7. After protocol transgressions were corrected the patient was successfully treated and satisfactory biochemical control achieved without placing the patient at increased risk of bleeding. Training and vigilance in the use of citrate is essential to maintain patient safety.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Patient consent Obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.